INOVIQ Confirms positive EXO-NET results in ovarian cancer study
INOVIQ (IIQ) confirms positive results during its testing for ovarian cancer
The company wrapped up...
INOVIQ Granted SubB2M US patent for diagnostic applications
INOVIQ (IIQ) receives a US patent that covers its SubB2M technology and provides intellectual property protection...
INOVIQ Receives Australian patent for SubB2M technology
INOVIQ (IIQ) receives an Australian patent for its SubB2M technology, which the company now holds exclusive worldwide...
